-
New SVS president outlines priorities for his tenure as Society aims to reach out

Michael Dalsing, MD, who took over as Society for Vascular Surgery (SVS) president at the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), talks about the priorities he has set out for his time at the helm, which include advocating for vascular surgery amid the recurring threat of Medicare payment cuts, furthering the Society’s…
-
ALI can occur with or without atherosclerotic disease, portends worse prognosis in COVID-19 patients, VESS session told

Acute limb ischemia (ALI) can occur with or without atherosclerotic disease and portends a worse prognosis in patients with COVID-19. This risk persists after COVID-19 infection due to a lingering co-inflammatory state, and D-dimer may be a useful screening test in at-risk patients. This is according to Max Wohlauer, MD, assistant professor of surgery at…
-
Greenberg Lecture raises prospect that ‘less is more and more is less’ with aortic disease treatment

Jan S. Brunkwall, MD, from the University of Cologne in Cologne, Germany, delivered the Roy Greenberg Distinguished Lecture at the 2022 Vascular Annual Meeting (VAM), telling attendees “more is less, and less is more!” when it comes to treatment for aortic disease. “After many years with open surgery, the endovascular technique came into our armamentarium,”…
-
Vascular Surgery Interest Groups propel students’ awareness and engagement in the specialty, VAM 2022 hears

A study of the impact of Vascular Surgery Interest Groups (VSIGs) can have on piquing awareness and engagement of medical students in the specialty found a spike among first years taking electives in vascular surgery after a series of interest group meetings were initiated. The finding was delivered under the title “Gaining access: Events with…
-
An antidote for burnout: Vascular surgeons as hospital administrators

The much-maligned electronic health record (EHR)—sometimes referred to as electronic medical record, or EMR—is not among the causes of burnout, per se, but rather a symptom, the 2022 Vascular Annual Meeting (VAM) heard during the John Homans Lecture on the Saturday morning of the Boston gathering (June 15–18). “Burnout is accepted by us as an…
-
Female sex ‘should be considered an independent risk factor’ for new stroke occurrence after carotid revascularization in symptomatic patients

A preliminary report lends evidence to support female sex being considered as an independent risk factor for new stroke occurrence after carotid revascularization in symptomatic patients, according to a research team from Italy who presented at the International Chapter Forum during the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18). Presenting author Pasqualino Sirignano,…
-
Study of post-carotid endarterectomy surveillance prompts protocol discussion

The results of an analysis of nearly 2,000 carotid endarterectomies (CEAs) “challenge the notion” that patients benefit significantly from the current post-operative surveillance guidelines, and suggest that these may be contributing to “oversurveillance”—an issue that should be addressed in future protocols for patient management post-CEA. These were among the talking points to emerge from a…
-
VAM 2022 Opening Ceremony: ‘Our Society is what it is because of you,’ SVS members hear

From the first Vascular Annual Meeting (VAM) that featured just eight papers, to VAM 2022 with many more times that number of presentations, each gathering through this year’s 75th edition has featured research, friendships and the desire to improve patient care. “For 75 years, vascular surgeons have been demonstrating their ingenuity, tenacity, and collaboration at…
-
First results from BEST-CLI poised to reveal ‘very low’ quality of life for patients entering the trial, especially women

An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual Meeting (VAM) demonstrated patient-specific variables such as self-reported female gender, current smoking, impaired mobility and opioid use are associated with lower health-related quality of life (HR-QOL) as captured by multiple measurement…
-
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury patients

The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients with traumatic brain injury (TBI), a new study presented at the 2022 Vascular Annual Meeting (VAM) indicated. The finding was a central conclusion from data delivered by Rafael Lozano, MD, a…

